The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study.

Remijn-Nelissen, Linda; Verschuuren, Jan J G M; Tannemaat, Martijn R

Remijn-Nelissen, Linda; Verschuuren, Jan J G M; Tannemaat, Martijn R.

Afiliação

Remijn-Nelissen L; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
Tannemaat MR; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands. Electronic address: m.r.tannemaat@lumc.nl.

Neuromuscul Disord ; 32(10): 790-799, 2022 10.

Article em En | MEDLINE | ID: mdl-36184373

Assuntos

Miastenia Gravis; Brometo de Piridostigmina; Humanos; Brometo de Piridostigmina/efeitos adversos; Estudos Transversais; Miastenia Gravis/tratamento farmacológico; Miastenia Gravis/induzido quimicamente; Debilidade Muscular/induzido quimicamente

Palavras-chave

Acetylcholinesterase inhibitor; Myasthenia Gravis; Pyridostigmine; Side effects; Symptomatic treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Brometo de Piridostigmina / Miastenia Gravis Tipo de estudo: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuromuscul Disord Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google